Kane Biotech's total assets for Q2 2025 were C$3.81M, an increase of 38.29% from the previous quarter. TSE:KNE total liabilities were C$4.05M for the fiscal quarter, a 4.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.